Company Filing History:
Years Active: 1998
Title: Cary H Lai: Innovator in Protein-Tyrosine Kinase Research
Introduction
Cary H Lai is a prominent inventor based in La Jolla, CA (US). He has made significant contributions to the field of protein-tyrosine kinases, with a focus on the development of novel receptor subtypes. His work has led to advancements in understanding the genetic encoding of these proteins, which play crucial roles in cellular signaling.
Latest Patents
Cary H Lai holds 2 patents that highlight his innovative research. His latest patents include:
1. **Protein-tyrosine kinase genes** - This invention provides pure receptor protein tyrosine kinase (PTK) subtypes, specifically tyro-1-8 and tyro-10-12. It includes polynucleotides encoding these PTK subtypes and the use of oligonucleotides that align with the flanking regions of the receptor PTK subtypes, facilitating the amplification of the polynucleotides.
2. **Tyro-3 protein tyrosine kinase** - This patent introduces a novel protein tyrosine kinase (PTK) designated as tyro-3. It also provides polynucleotides encoding tyro-3, which is identified and characterized as being expressed in brain tissue.
Career Highlights
Cary H Lai is affiliated with the Salk Institute for Biological Studies, where he conducts his research. His work has been instrumental in advancing the understanding of protein-tyrosine kinases and their implications in various biological processes.
Collaborations
Cary has collaborated with notable researchers in his field, including Greg Erwin Lemke, enhancing the impact of his work through shared expertise and knowledge.
Conclusion
Cary H Lai's contributions to the field of protein-tyrosine kinases have paved the way for further research and innovation. His patents reflect a commitment to advancing scientific understanding and potential therapeutic applications.